Longevity
FOXO4-DRI
FOXO4–p53 disruptor studied in senescent-cell clearance models. Narrow research use.
- Form
- Lyophilized powder
- Vial
- 10 mg
- Price
- $196.00
Protocol waiting on subject
Set age and sex in the panel — the sheet writes itself on this page.
- FOXO4–p53 disruptor (D-retro-inverso). Senescent-cell apoptosis models. Not a GH secretagogue, not an IGF analog, not a mitochondrial peptide.
- NARROW research use. 5 mg three times weekly × 21 days, then stop. Do not roll into a second senolytic block without a defined pause.
- Cancer history = caution. p53-axis compound. This desk does not escalate. Clinician owns any oncology-adjacent stack; malignancy flag is not a titration target.